~~<i id='933E524034'><strike id='933E524034'><tt id='933E524034'><pre id='933E524034'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

hotspot

author：leisure time 2025-10-01 21:35:14 - browse：361

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Why do women spend more than men on medical expenses?

hotspot

entertainment

hotspot

focus

hotspot

AkidneydonorwatchesasaconsentformissignedbyawitnessbeforeakidneytransplantoperationatJohnsHopkinsHos

WSS

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

Living organ donors deserve priority status for transplants

WHO recommends dropping component of many flu vaccines

Patients, doctors are clashing about side effects of hormonal birth control

Biogen nominates mother of director’s child to replace him on board

How one patient went off dialysis — and others can too

leisure time

hotspot

hotspot

Apple is now the first public company to be valued at $3 trillion

Reanimated hearts work just as well for transplants, study finds

Peter Hotez and the public health issue of online harassment

Living organ donors deserve priority status for transplants

Hollywood unions extend contract negotiations for actors

Altering the blood type of lungs raises potential for universal organs for transplants

The high cost of giving birth even with insurance

Would Medicare drug price negotiations stall in a shutdown?

The high cost of giving birth even with insurance

How one patient went off dialysis — and others can too

entertainment

How to fix the rural physician shortage in the U.S.

FDA seeks to regulate lab

Sudafed saga points to U.S. issues with evaluating older drugs

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

Biogen shutters digital health group, ends Apple study, in cost cutting move

Tennessee law changes starting July 1 will restrict trans health care and fund more school safety

hotspot

focus

focus

hotspot